AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,537,000 | -44.1% | 113,842 | 0.0% | 0.04% | -29.1% |
| Q4 2019 | $2,752,000 | +39.5% | 113,842 | +10.9% | 0.06% | +25.0% |
| Q3 2019 | $1,973,000 | +22.8% | 102,649 | +88.7% | 0.04% | +15.8% |
| Q2 2019 | $1,607,000 | +6.7% | 54,384 | +71.6% | 0.04% | +8.6% |
| Q1 2019 | $1,506,000 | +31.6% | 31,700 | 0.0% | 0.04% | -10.3% |
| Q4 2018 | $1,144,000 | -41.4% | 31,700 | 0.0% | 0.04% | -29.1% |
| Q3 2018 | $1,951,000 | -23.2% | 31,700 | -15.7% | 0.06% | -8.3% |
| Q2 2018 | $2,540,000 | +24.6% | 37,600 | 0.0% | 0.06% | +5.3% |
| Q1 2018 | $2,039,000 | -9.2% | 37,600 | 0.0% | 0.06% | -5.0% |
| Q4 2017 | $2,246,000 | +22.9% | 37,600 | 0.0% | 0.06% | +30.4% |
| Q3 2017 | $1,827,000 | -18.2% | 37,600 | -11.5% | 0.05% | -24.6% |
| Q2 2017 | $2,233,000 | +15.9% | 42,500 | 0.0% | 0.06% | +15.1% |
| Q1 2017 | $1,927,000 | -18.8% | 42,500 | -32.2% | 0.05% | -24.3% |
| Q4 2016 | $2,373,000 | -20.4% | 62,700 | -20.6% | 0.07% | 0.0% |
| Q3 2016 | $2,981,000 | +38.8% | 79,000 | -35.2% | 0.07% | +32.1% |
| Q2 2016 | $2,147,000 | +44.8% | 122,000 | 0.0% | 0.05% | +60.6% |
| Q1 2016 | $1,483,000 | -50.1% | 122,000 | 0.0% | 0.03% | -49.2% |
| Q4 2015 | $2,970,000 | +37.2% | 122,000 | 0.0% | 0.06% | +10.2% |
| Q3 2015 | $2,164,000 | +0.5% | 122,000 | 0.0% | 0.06% | +37.2% |
| Q2 2015 | $2,153,000 | +16.4% | 122,000 | +106.8% | 0.04% | +16.2% |
| Q1 2015 | $1,849,000 | +7.4% | 59,000 | 0.0% | 0.04% | +12.1% |
| Q4 2014 | $1,722,000 | +41.1% | 59,000 | 0.0% | 0.03% | +32.0% |
| Q3 2014 | $1,220,000 | – | 59,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|